Literature DB >> 30632012

Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies.

Lei Meng1,2, Liang Shen3,4, Hong-Fang Ji5,6.   

Abstract

Identifying modifiable risk factors for Parkinson's disease (PD) to help prevent this disease has attracted increasing interest in recent years for the limited effective drugs at present. Despite many studies indicated that infection acts as a risk factor for PD, there is no quantitative assessment of the impact of viral and bacterial infections on the risk of developing PD. The present study performed a meta-analysis on the basis of 38 datasets from 13 studies covering 287,773 PD cases and 7,102,901 controls to ascertain the association between PD and infection and the differences in the strength of the viral and bacterial infections. The overall meta-analytic results indicated that individuals with infection had a 20% increased risk of PD compared with controls (OR 1.20, 95%CI 1.07-1.32). The subgroup analysis according to the type of infection found that bacterial infection had a significant impact on increased risk of PD (OR 1.40, 95%CI 1.32-1.48). The present analysis indicated that infection could increase the risk of developing PD, and physician should be aware of the risk of developing PD in subjects with infection.

Entities:  

Keywords:  Bacteria; Infection; Meta-analysis; Parkinson’s disease; Virus

Year:  2019        PMID: 30632012     DOI: 10.1007/s13365-018-0707-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  41 in total

1.  An essay on the shaking palsy. 1817.

Authors:  James Parkinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

Review 2.  Genetic clues to the pathogenesis of Parkinson's disease.

Authors:  Miquel Vila; Serge Przedborski
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

3.  Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

Authors:  K Weissenborn; J C Ennen; M Bokemeyer; B Ahl; U Wurster; H Tillmann; C Trebst; H Hecker; G Berding
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

4.  Association of coffee and caffeine intake with the risk of Parkinson disease.

Authors:  G W Ross; R D Abbott; H Petrovitch; D M Morens; A Grandinetti; K H Tung; C M Tanner; K H Masaki; P L Blanchette; J D Curb; J S Popper; L R White
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

5.  Etiology of Parkinson's disease.

Authors:  Anthony H V Schapira
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

Review 6.  Inflammation as a causative factor in the aetiology of Parkinson's disease.

Authors:  P S Whitton
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

7.  Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia.

Authors:  Marion Danzer; Claudia Samberger; Rudolf Schicho; Irmgard Th Lippe; Peter Holzer
Journal:  Eur J Neurosci       Date:  2004-01       Impact factor: 3.386

Review 8.  Inflammation and infection in Parkinson's disease.

Authors:  H Arai; T Furuya; Y Mizuno; H Mochizuki
Journal:  Histol Histopathol       Date:  2006-06       Impact factor: 2.303

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

Review 10.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation.

Authors:  Bin Liu; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more
  13 in total

Review 1.  Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's Disease.

Authors:  Kathleen M Shannon
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease.

Authors:  Jaime Silva; Felipe Patricio; Aleidy Patricio-Martínez; Gerardo Santos-López; Lilia Cedillo; Yousef Tizabi; Ilhuicamina Daniel Limón
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

Review 3.  Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System.

Authors:  Samuel Hess; Anura Rambukkana
Journal:  Microbiol Spectr       Date:  2019-07

Review 4.  Covid-19 Infection and Parkinsonism: Is There a Link?

Authors:  Rabia Bouali-Benazzouz; Abdelhamid Benazzouz
Journal:  Mov Disord       Date:  2021-06-08       Impact factor: 9.698

Review 5.  Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19.

Authors:  Dipak Kumar; Sadaf Jahan; Andleeb Khan; Arif Jamal Siddiqui; Neeru Singh Redhu; Johra Khan; Saeed Banwas; Bader Alshehri; Mohammed Alaidarous
Journal:  Mol Neurobiol       Date:  2021-03-14       Impact factor: 5.590

6.  Back to the future: lessons from past viral infections and the link with Parkinson's disease.

Authors:  Eilis Dowd; Declan P McKernan
Journal:  Neuronal Signal       Date:  2021-04-16

Review 7.  Parkinson's Disease in Light of the COVID-19 Pandemic.

Authors:  Anna Drelich-Zbroja; Mateusz Cheda; Maryla Kuczyńska; Izabela Dąbrowska; Ewa Kopyto; Izabela Halczuk
Journal:  Brain Sci       Date:  2022-01-21

8.  COVID-19: The cynosure of rise of Parkinson's disease.

Authors:  Prashanth Lingappa Kukkle
Journal:  Int Rev Neurobiol       Date:  2022-07-22       Impact factor: 4.280

Review 9.  COVID-19: dealing with a potential risk factor for chronic neurological disorders.

Authors:  Tommaso Schirinzi; Doriana Landi; Claudio Liguori
Journal:  J Neurol       Date:  2020-08-27       Impact factor: 4.849

Review 10.  Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?

Authors:  Lea Krey; Meret Koroni Huber; Günter U Höglinger; Florian Wegner
Journal:  Brain Sci       Date:  2021-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.